Zynex Appoints Steven Dyson as CEO, Expands Medical Device Portfolio

Zynex, Inc. has announced the arrival of Steven Dyson as their new CEO. Zynex develops and manufactures medical devices for pain management and rehabilitation, as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems. Their products include NexWave, NeuroMove, InWave, E-Wave, M-Wave, and CM-1500. Dyson brings experience in the medical device industry to the role.

Zynex, Inc., a medical technology company focused on non-invasive medical devices, has announced significant leadership changes with the arrival of Steven Dyson as CEO and several key executive appointments effective August 18, 2025. The new leadership team includes Vikram Bajaj as CFO, John T. Bibb as Chief Legal Officer, Ajay Gopal as EVP of Sales, and Agnes Powell as VP of Billing [2].

Zynex develops, manufactures, and markets medical devices used for pain management and rehabilitation, as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. The company's products include NexWave, NeuroMove, InWave, E-Wave, M-Wave, and CM-1500 [1].

The appointment of Vikram Bajaj as CFO brings 20 years of finance leadership with specialized experience in M&A and capital markets within med-tech, potentially signaling future acquisition strategies [2]. Similarly, John Bibb's extensive background in complex litigation, compliance remediation, and M&A execution suggests the company may be addressing underlying governance or compliance concerns [2].

Ajay Gopal's appointment as EVP of Sales directly targets commercial execution, while Agnes Powell's selection as VP of Billing specifically addresses revenue cycle operations—both critical functions for a medical device company dependent on insurance reimbursements [2].

The executive leadership team will be completed by existing members Anna Lucsok (COO) and Donald Gregg (President of Zynex Monitoring Solutions). Chairman Thomas Sandgaard expressed confidence in the new team's ability to lead Zynex to new levels of success [2].

Zynex's leadership overhaul brings in seasoned med-tech executives with strong backgrounds, signaling a potential strategic shift. The incoming team's credentials are particularly noteworthy, with new CFO Vikram Bajaj and CLO John Bibb potentially addressing future acquisition strategies and underlying governance concerns [2].

References:

[1] https://www.marketscreener.com/news/zynex-names-vikram-bajaj-as-cfo-ce7c51dcd980f226
[2] https://www.stocktitan.net/news/ZYXI/zynex-announces-arrival-of-steven-dyson-as-ceo-and-appointment-of-n4wyp0hr12dr.html